Cancer Immunotherapies Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0077797
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:7.45
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 7.45 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
Cancer immunotherapy, also called biologic therapy, which can predominantly be classed as a form of targeted therapy, It is designed to stimulate the body's immune system to attack tumours.The global Cancer Immunotherapies market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2026, growing at a CAGR of xx% during 2019-2026. The objectives of this study are to define, segment, and project the size of the Cancer Immunotherapies market based on company, product type, end user and key regions.
This report studies the global market size of Cancer Immunotherapies in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Immunotherapies in these regions.
This research report categorizes the global Cancer Immunotherapies market by top players/brands, region, type and end user. This report also studies the global Cancer Immunotherapies market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen
AstraZeneca
Roche
Bristol-Myers Squibb
Bayer
Merck
ARMO BioSciences (Eli Lilly)
Novartis
Pfizer
Johnson & Johnson
AbbVie
Gilead Sciences
Market size by Product
Monoclonal Antibodies (MABs)
Cancer Vaccines
Immunomodulators
Adoptive Cell transfer
Checkpoint Inhibitors
Market size by End User
Breast Cancer
Leukemia
Lymphoma
Melanoma
Colorectal Cancer
Non-Small Cell Lung Cancer
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cancer Immunotherapies market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2026.
To understand the structure of Cancer Immunotherapies market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cancer Immunotherapies companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cancer Immunotherapies submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cancer Immunotherapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Immunotherapies market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Cancer Immunotherapies Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cancer Immunotherapies Market Size Growth Rate by Product
1.4.2 Monoclonal Antibodies (MABs)
1.4.3 Cancer Vaccines
1.4.4 Immunomodulators
1.4.5 Adoptive Cell transfer
1.4.6 Checkpoint Inhibitors
1.5 Market by End User
1.5.1 Global Cancer Immunotherapies Market Size Growth Rate by End User
1.5.2 Breast Cancer
1.5.3 Leukemia
1.5.4 Lymphoma
1.5.5 Melanoma
1.5.6 Colorectal Cancer
1.5.7 Non-Small Cell Lung Cancer
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Immunotherapies Market Size
2.1.1 Global Cancer Immunotherapies Revenue 2014-2025
2.1.2 Global Cancer Immunotherapies Sales 2014-2025
2.2 Cancer Immunotherapies Growth Rate by Regions
2.2.1 Global Cancer Immunotherapies Sales by Regions
2.2.2 Global Cancer Immunotherapies Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Cancer Immunotherapies Sales by Manufacturers
3.1.1 Cancer Immunotherapies Sales by Manufacturers
3.1.2 Cancer Immunotherapies Sales Market Share by Manufacturers
3.1.3 Global Cancer Immunotherapies Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Immunotherapies Revenue by Manufacturers
3.2.1 Cancer Immunotherapies Revenue by Manufacturers (2014-2019)
3.2.2 Cancer Immunotherapies Revenue Share by Manufacturers (2014-2019)
3.3 Cancer Immunotherapies Price by Manufacturers
3.4 Cancer Immunotherapies Manufacturing Base Distribution, Product Types
3.4.1 Cancer Immunotherapies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Immunotherapies Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Immunotherapies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Cancer Immunotherapies Sales by Product
4.2 Global Cancer Immunotherapies Revenue by Product
4.3 Cancer Immunotherapies Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Cancer Immunotherapies Breakdown Data by End User
6 North America
6.1 North America Cancer Immunotherapies by Countries
6.1.1 North America Cancer Immunotherapies Sales by Countries
6.1.2 North America Cancer Immunotherapies Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Cancer Immunotherapies by Product
6.3 North America Cancer Immunotherapies by End User
7 Europe
7.1 Europe Cancer Immunotherapies by Countries
7.1.1 Europe Cancer Immunotherapies Sales by Countries
7.1.2 Europe Cancer Immunotherapies Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Immunotherapies by Product
7.3 Europe Cancer Immunotherapies by End User
8 Asia Pacific
8.1 Asia Pacific Cancer Immunotherapies by Countries
8.1.1 Asia Pacific Cancer Immunotherapies Sales by Countries
8.1.2 Asia Pacific Cancer Immunotherapies Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Cancer Immunotherapies by Product
8.3 Asia Pacific Cancer Immunotherapies by End User
9 Central & South America
9.1 Central & South America Cancer Immunotherapies by Countries
9.1.1 Central & South America Cancer Immunotherapies Sales by Countries
9.1.2 Central & South America Cancer Immunotherapies Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Cancer Immunotherapies by Product
9.3 Central & South America Cancer Immunotherapies by End User
10 Middle East and Africa
10.1 Middle East and Africa Cancer Immunotherapies by Countries
10.1.1 Middle East and Africa Cancer Immunotherapies Sales by Countries
10.1.2 Middle East and Africa Cancer Immunotherapies Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Cancer Immunotherapies by Product
10.3 Middle East and Africa Cancer Immunotherapies by End User
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Business Overview
11.1.3 Amgen Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen Cancer Immunotherapies Products Offered
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 Company Business Overview
11.2.3 AstraZeneca Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.2.4 AstraZeneca Cancer Immunotherapies Products Offered
11.2.5 AstraZeneca Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.3 Roche Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Roche Cancer Immunotherapies Products Offered
11.3.5 Roche Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Company Business Overview
11.4.3 Bristol-Myers Squibb Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bristol-Myers Squibb Cancer Immunotherapies Products Offered
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Company Business Overview
11.5.3 Bayer Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bayer Cancer Immunotherapies Products Offered
11.5.5 Bayer Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Company Business Overview
11.6.3 Merck Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Merck Cancer Immunotherapies Products Offered
11.6.5 Merck Recent Development
11.7 ARMO BioSciences (Eli Lilly)
11.7.1 ARMO BioSciences (Eli Lilly) Company Details
11.7.2 Company Business Overview
11.7.3 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.7.4 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Products Offered
11.7.5 ARMO BioSciences (Eli Lilly) Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Novartis Cancer Immunotherapies Products Offered
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Company Business Overview
11.9.3 Pfizer Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Pfizer Cancer Immunotherapies Products Offered
11.9.5 Pfizer Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Company Business Overview
11.10.3 Johnson & Johnson Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Johnson & Johnson Cancer Immunotherapies Products Offered
11.10.5 Johnson & Johnson Recent Development
11.11 AbbVie
11.12 Gilead Sciences
12 Future Forecast
12.1 Cancer Immunotherapies Market Forecast by Regions
12.1.1 Global Cancer Immunotherapies Sales Forecast by Regions 2019-2025
12.1.2 Global Cancer Immunotherapies Revenue Forecast by Regions 2019-2025
12.2 Cancer Immunotherapies Market Forecast by Product
12.2.1 Global Cancer Immunotherapies Sales Forecast by Product 2019-2025
12.2.2 Global Cancer Immunotherapies Revenue Forecast by Product 2019-2025
12.3 Cancer Immunotherapies Market Forecast by End User
12.4 North America Cancer Immunotherapies Forecast
12.5 Europe Cancer Immunotherapies Forecast
12.6 Asia Pacific Cancer Immunotherapies Forecast
12.7 Central & South America Cancer Immunotherapies Forecast
12.8 Middle East and Africa Cancer Immunotherapies Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Immunotherapies Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Cancer Immunotherapies Product Picture
Table Cancer Immunotherapies Market Segments
Table Key Manufacturers Cancer Immunotherapies Covered
Table Global Cancer Immunotherapies Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Cancer Immunotherapies Sales Market Share by Product 2014-2025
Figure Monoclonal Antibodies (MABs) Product Picture
Table Major Manufacturers of Monoclonal Antibodies (MABs)
Figure Cancer Vaccines Product Picture
Table Major Manufacturers of Cancer Vaccines
Figure Immunomodulators Product Picture
Table Major Manufacturers of Immunomodulators
Figure Adoptive Cell transfer Product Picture
Table Major Manufacturers of Adoptive Cell transfer
Figure Checkpoint Inhibitors Product Picture
Table Major Manufacturers of Checkpoint Inhibitors
Table Global Cancer Immunotherapies Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Breast Cancer
Figure Leukemia
Figure Lymphoma
Figure Melanoma
Figure Colorectal Cancer
Figure Non-Small Cell Lung Cancer
Figure Cancer Immunotherapies Report Years Considered
Figure Global Cancer Immunotherapies Market Size 2014-2025 (Million US$)
Figure Global Cancer Immunotherapies Sales 2014-2025 (K Units)
Table Global Cancer Immunotherapies Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Cancer Immunotherapies Sales by Regions 2014-2019 (K Units)
Table Global Cancer Immunotherapies Sales Market Share by Regions 2014-2019
Figure Global Cancer Immunotherapies Sales Market Share by Regions 2014-2019
Figure 2018 Global Cancer Immunotherapies Sales Market Share by Regions
Table Global Cancer Immunotherapies Revenue by Regions 2014-2019 (Million US$)
Table Global Cancer Immunotherapies Revenue Market Share by Regions 2014-2019
Figure Global Cancer Immunotherapies Revenue Market Share by Regions 2014-2019
Figure 2018 Global Cancer Immunotherapies Revenue Market Share by Regions
Table Global Cancer Immunotherapies Sales by Manufacturers (2014-2019) (K Units)
Table Global Cancer Immunotherapies Sales Share by Manufacturers (2014-2019)
Figure Global Cancer Immunotherapies Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Cancer Immunotherapies Revenue by Manufacturers (2014-2019) (Million USD)
Table Cancer Immunotherapies Revenue Share by Manufacturers (2014-2019)
Figure Cancer Immunotherapies Value Share by Manufacturers in 2018
Table Key Manufacturers Cancer Immunotherapies Price (2014-2019) (USD/Unit)
Table Cancer Immunotherapies Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Cancer Immunotherapies Product Type
Table Date of International Manufacturers Enter into Cancer Immunotherapies Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table Global Cancer Immunotherapies Sales Share by Product (2014-2019)
Figure Global Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure Global Cancer Immunotherapies Sales Market Share by Product in 2018
Table Global Cancer Immunotherapies Revenue by Product (2014-2019) (Million US$)
Table Global Cancer Immunotherapies Revenue Share by Product (2014-2019)
Figure Global Cancer Immunotherapies Revenue Market Share by Product (2014-2019)
Figure Global Cancer Immunotherapies Revenue Market Share by Product in 2018
Table Cancer Immunotherapies Price by Product 2014-2019 (USD/Unit)
Table Global Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table Global Cancer Immunotherapies Sales Share by End User (2014-2019)
Figure Global Sales Cancer Immunotherapies Market Share by End User (2014-2019)
Figure Global Sales Cancer Immunotherapies Market Share by End User in 2018
Figure North America Cancer Immunotherapies Sales Growth Rate 2014-2019 (K Units)
Figure North America Cancer Immunotherapies Revenue Growth Rate 2014-2019 (Million US$)
Table North America Cancer Immunotherapies Sales by Countries (2014-2019) (K Units)
Table North America Cancer Immunotherapies Sales Market Share by Countries (2014-2019)
Figure 2018 North America Cancer Immunotherapies Sales Market Share by Countries
Table North America Cancer Immunotherapies Revenue by Countries (2014-2019) (Million US$)
Table North America Cancer Immunotherapies Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Cancer Immunotherapies Revenue Market Share by Countries
Figure United States Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure United States Cancer Immunotherapies Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Canada Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Table North America Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table North America Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure 2018 North America Cancer Immunotherapies Market Share by Product
Table North America Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table North America Cancer Immunotherapies Sales Market Share by End User (2014-2019)
Figure 2018 North America Cancer Immunotherapies Market Share by End User
Figure Europe Cancer Immunotherapies Sales Growth Rate 2014-2019 (K Units)
Figure Europe Cancer Immunotherapies Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Cancer Immunotherapies Sales by Countries (2014-2019) (K Units)
Table Europe Cancer Immunotherapies Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Cancer Immunotherapies Sales Market Share by Countries
Table Europe Cancer Immunotherapies Revenue by Countries (2014-2019) (Million US$)
Table Europe Cancer Immunotherapies Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Cancer Immunotherapies Revenue Market Share by Countries
Figure Germany Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Germany Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure France Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure France Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure UK Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Italy Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Russia Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table Europe Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure 2018 Europe Cancer Immunotherapies Market Share by Product
Table Europe Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table Europe Cancer Immunotherapies Sales Market Share by End User (2014-2019)
Figure 2018 Europe Cancer Immunotherapies Market Share by End User
Figure Asia Pacific Cancer Immunotherapies Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Cancer Immunotherapies Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Cancer Immunotherapies Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Cancer Immunotherapies Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cancer Immunotherapies Sales Market Share by Countries
Table Asia Pacific Cancer Immunotherapies Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Cancer Immunotherapies Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cancer Immunotherapies Revenue Market Share by Countries
Figure China Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure China Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Japan Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Korea Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure India Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure India Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Australia Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table Asia Pacific Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Cancer Immunotherapies Market Share by Product
Table Asia Pacific Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table Asia Pacific Cancer Immunotherapies Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Cancer Immunotherapies Market Share by End User
Figure Central & South America Cancer Immunotherapies Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Cancer Immunotherapies Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Cancer Immunotherapies Sales by Countries (2014-2019) (K Units)
Table Central & South America Cancer Immunotherapies Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cancer Immunotherapies Sales Market Share by Countries
Table Central & South America Cancer Immunotherapies Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Cancer Immunotherapies Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cancer Immunotherapies Revenue Market Share by Countries
Figure Brazil Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table Central & South America Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Cancer Immunotherapies Market Share by Product
Table Central & South America Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table Central & South America Cancer Immunotherapies Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Cancer Immunotherapies Market Share by End User
Figure Middle East and Africa Cancer Immunotherapies Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Cancer Immunotherapies Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Cancer Immunotherapies Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Cancer Immunotherapies Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cancer Immunotherapies Sales Market Share by Countries
Table Middle East and Africa Cancer Immunotherapies Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Cancer Immunotherapies Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cancer Immunotherapies Revenue Market Share by Countries
Figure GCC Countries Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Cancer Immunotherapies Market Share by Product
Table Middle East and Africa Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Cancer Immunotherapies Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Cancer Immunotherapies Market Share by End User
Table Amgen Company Details
Table Amgen Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Roche Company Details
Table Roche Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Bayer Company Details
Table Bayer Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Merck Company Details
Table Merck Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table ARMO BioSciences (Eli Lilly) Company Details
Table ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ARMO BioSciences (Eli Lilly) Recent Development
Table Novartis Company Details
Table Novartis Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table AbbVie Company Details
Table Gilead Sciences Company Details
Table Global Cancer Immunotherapies Sales Forecast by Regions 2019-2025 (K Units)
Table Global Cancer Immunotherapies Sales Market Share Forecast by Regions 2019-2025
Table Global Cancer Immunotherapies Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Cancer Immunotherapies Revenue Market Share Forecast by Regions 2019-2025
Table Global Cancer Immunotherapies Sales Forecast by Product 2019-2025 (K Units)
Table Global Cancer Immunotherapies Sales Market Share Forecast by Product 2019-2025
Table Global Cancer Immunotherapies Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Cancer Immunotherapies Revenue Market Share Forecast by Product 2019-2025
Table Global Cancer Immunotherapies Sales Forecast by End User 2019-2025 (K Units)
Table Global Cancer Immunotherapies Sales Market Share Forecast by End User 2019-2025
Figure North America Cancer Immunotherapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Cancer Immunotherapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Cancer Immunotherapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Cancer Immunotherapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Cancer Immunotherapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Cancer Immunotherapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Cancer Immunotherapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Cancer Immunotherapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Cancer Immunotherapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Cancer Immunotherapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Cancer Immunotherapies Value Chain
Table Cancer Immunotherapies Customers List
Table Cancer Immunotherapies Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 Study Coverage
1.1 Cancer Immunotherapies Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cancer Immunotherapies Market Size Growth Rate by Product
1.4.2 Monoclonal Antibodies (MABs)
1.4.3 Cancer Vaccines
1.4.4 Immunomodulators
1.4.5 Adoptive Cell transfer
1.4.6 Checkpoint Inhibitors
1.5 Market by End User
1.5.1 Global Cancer Immunotherapies Market Size Growth Rate by End User
1.5.2 Breast Cancer
1.5.3 Leukemia
1.5.4 Lymphoma
1.5.5 Melanoma
1.5.6 Colorectal Cancer
1.5.7 Non-Small Cell Lung Cancer
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Immunotherapies Market Size
2.1.1 Global Cancer Immunotherapies Revenue 2014-2025
2.1.2 Global Cancer Immunotherapies Sales 2014-2025
2.2 Cancer Immunotherapies Growth Rate by Regions
2.2.1 Global Cancer Immunotherapies Sales by Regions
2.2.2 Global Cancer Immunotherapies Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Cancer Immunotherapies Sales by Manufacturers
3.1.1 Cancer Immunotherapies Sales by Manufacturers
3.1.2 Cancer Immunotherapies Sales Market Share by Manufacturers
3.1.3 Global Cancer Immunotherapies Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Immunotherapies Revenue by Manufacturers
3.2.1 Cancer Immunotherapies Revenue by Manufacturers (2014-2019)
3.2.2 Cancer Immunotherapies Revenue Share by Manufacturers (2014-2019)
3.3 Cancer Immunotherapies Price by Manufacturers
3.4 Cancer Immunotherapies Manufacturing Base Distribution, Product Types
3.4.1 Cancer Immunotherapies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Immunotherapies Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Immunotherapies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Cancer Immunotherapies Sales by Product
4.2 Global Cancer Immunotherapies Revenue by Product
4.3 Cancer Immunotherapies Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Cancer Immunotherapies Breakdown Data by End User
6 North America
6.1 North America Cancer Immunotherapies by Countries
6.1.1 North America Cancer Immunotherapies Sales by Countries
6.1.2 North America Cancer Immunotherapies Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Cancer Immunotherapies by Product
6.3 North America Cancer Immunotherapies by End User
7 Europe
7.1 Europe Cancer Immunotherapies by Countries
7.1.1 Europe Cancer Immunotherapies Sales by Countries
7.1.2 Europe Cancer Immunotherapies Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Immunotherapies by Product
7.3 Europe Cancer Immunotherapies by End User
8 Asia Pacific
8.1 Asia Pacific Cancer Immunotherapies by Countries
8.1.1 Asia Pacific Cancer Immunotherapies Sales by Countries
8.1.2 Asia Pacific Cancer Immunotherapies Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Cancer Immunotherapies by Product
8.3 Asia Pacific Cancer Immunotherapies by End User
9 Central & South America
9.1 Central & South America Cancer Immunotherapies by Countries
9.1.1 Central & South America Cancer Immunotherapies Sales by Countries
9.1.2 Central & South America Cancer Immunotherapies Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Cancer Immunotherapies by Product
9.3 Central & South America Cancer Immunotherapies by End User
10 Middle East and Africa
10.1 Middle East and Africa Cancer Immunotherapies by Countries
10.1.1 Middle East and Africa Cancer Immunotherapies Sales by Countries
10.1.2 Middle East and Africa Cancer Immunotherapies Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Cancer Immunotherapies by Product
10.3 Middle East and Africa Cancer Immunotherapies by End User
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Business Overview
11.1.3 Amgen Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen Cancer Immunotherapies Products Offered
11.1.5 Amgen Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 Company Business Overview
11.2.3 AstraZeneca Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.2.4 AstraZeneca Cancer Immunotherapies Products Offered
11.2.5 AstraZeneca Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.3 Roche Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Roche Cancer Immunotherapies Products Offered
11.3.5 Roche Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Company Business Overview
11.4.3 Bristol-Myers Squibb Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bristol-Myers Squibb Cancer Immunotherapies Products Offered
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Company Business Overview
11.5.3 Bayer Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bayer Cancer Immunotherapies Products Offered
11.5.5 Bayer Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Company Business Overview
11.6.3 Merck Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Merck Cancer Immunotherapies Products Offered
11.6.5 Merck Recent Development
11.7 ARMO BioSciences (Eli Lilly)
11.7.1 ARMO BioSciences (Eli Lilly) Company Details
11.7.2 Company Business Overview
11.7.3 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.7.4 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Products Offered
11.7.5 ARMO BioSciences (Eli Lilly) Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Novartis Cancer Immunotherapies Products Offered
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Company Business Overview
11.9.3 Pfizer Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Pfizer Cancer Immunotherapies Products Offered
11.9.5 Pfizer Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Company Business Overview
11.10.3 Johnson & Johnson Cancer Immunotherapies Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Johnson & Johnson Cancer Immunotherapies Products Offered
11.10.5 Johnson & Johnson Recent Development
11.11 AbbVie
11.12 Gilead Sciences
12 Future Forecast
12.1 Cancer Immunotherapies Market Forecast by Regions
12.1.1 Global Cancer Immunotherapies Sales Forecast by Regions 2019-2025
12.1.2 Global Cancer Immunotherapies Revenue Forecast by Regions 2019-2025
12.2 Cancer Immunotherapies Market Forecast by Product
12.2.1 Global Cancer Immunotherapies Sales Forecast by Product 2019-2025
12.2.2 Global Cancer Immunotherapies Revenue Forecast by Product 2019-2025
12.3 Cancer Immunotherapies Market Forecast by End User
12.4 North America Cancer Immunotherapies Forecast
12.5 Europe Cancer Immunotherapies Forecast
12.6 Asia Pacific Cancer Immunotherapies Forecast
12.7 Central & South America Cancer Immunotherapies Forecast
12.8 Middle East and Africa Cancer Immunotherapies Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Immunotherapies Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Cancer Immunotherapies Product Picture
Table Cancer Immunotherapies Market Segments
Table Key Manufacturers Cancer Immunotherapies Covered
Table Global Cancer Immunotherapies Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Cancer Immunotherapies Sales Market Share by Product 2014-2025
Figure Monoclonal Antibodies (MABs) Product Picture
Table Major Manufacturers of Monoclonal Antibodies (MABs)
Figure Cancer Vaccines Product Picture
Table Major Manufacturers of Cancer Vaccines
Figure Immunomodulators Product Picture
Table Major Manufacturers of Immunomodulators
Figure Adoptive Cell transfer Product Picture
Table Major Manufacturers of Adoptive Cell transfer
Figure Checkpoint Inhibitors Product Picture
Table Major Manufacturers of Checkpoint Inhibitors
Table Global Cancer Immunotherapies Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Breast Cancer
Figure Leukemia
Figure Lymphoma
Figure Melanoma
Figure Colorectal Cancer
Figure Non-Small Cell Lung Cancer
Figure Cancer Immunotherapies Report Years Considered
Figure Global Cancer Immunotherapies Market Size 2014-2025 (Million US$)
Figure Global Cancer Immunotherapies Sales 2014-2025 (K Units)
Table Global Cancer Immunotherapies Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Cancer Immunotherapies Sales by Regions 2014-2019 (K Units)
Table Global Cancer Immunotherapies Sales Market Share by Regions 2014-2019
Figure Global Cancer Immunotherapies Sales Market Share by Regions 2014-2019
Figure 2018 Global Cancer Immunotherapies Sales Market Share by Regions
Table Global Cancer Immunotherapies Revenue by Regions 2014-2019 (Million US$)
Table Global Cancer Immunotherapies Revenue Market Share by Regions 2014-2019
Figure Global Cancer Immunotherapies Revenue Market Share by Regions 2014-2019
Figure 2018 Global Cancer Immunotherapies Revenue Market Share by Regions
Table Global Cancer Immunotherapies Sales by Manufacturers (2014-2019) (K Units)
Table Global Cancer Immunotherapies Sales Share by Manufacturers (2014-2019)
Figure Global Cancer Immunotherapies Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Cancer Immunotherapies Revenue by Manufacturers (2014-2019) (Million USD)
Table Cancer Immunotherapies Revenue Share by Manufacturers (2014-2019)
Figure Cancer Immunotherapies Value Share by Manufacturers in 2018
Table Key Manufacturers Cancer Immunotherapies Price (2014-2019) (USD/Unit)
Table Cancer Immunotherapies Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Cancer Immunotherapies Product Type
Table Date of International Manufacturers Enter into Cancer Immunotherapies Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table Global Cancer Immunotherapies Sales Share by Product (2014-2019)
Figure Global Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure Global Cancer Immunotherapies Sales Market Share by Product in 2018
Table Global Cancer Immunotherapies Revenue by Product (2014-2019) (Million US$)
Table Global Cancer Immunotherapies Revenue Share by Product (2014-2019)
Figure Global Cancer Immunotherapies Revenue Market Share by Product (2014-2019)
Figure Global Cancer Immunotherapies Revenue Market Share by Product in 2018
Table Cancer Immunotherapies Price by Product 2014-2019 (USD/Unit)
Table Global Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table Global Cancer Immunotherapies Sales Share by End User (2014-2019)
Figure Global Sales Cancer Immunotherapies Market Share by End User (2014-2019)
Figure Global Sales Cancer Immunotherapies Market Share by End User in 2018
Figure North America Cancer Immunotherapies Sales Growth Rate 2014-2019 (K Units)
Figure North America Cancer Immunotherapies Revenue Growth Rate 2014-2019 (Million US$)
Table North America Cancer Immunotherapies Sales by Countries (2014-2019) (K Units)
Table North America Cancer Immunotherapies Sales Market Share by Countries (2014-2019)
Figure 2018 North America Cancer Immunotherapies Sales Market Share by Countries
Table North America Cancer Immunotherapies Revenue by Countries (2014-2019) (Million US$)
Table North America Cancer Immunotherapies Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Cancer Immunotherapies Revenue Market Share by Countries
Figure United States Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure United States Cancer Immunotherapies Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Canada Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Table North America Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table North America Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure 2018 North America Cancer Immunotherapies Market Share by Product
Table North America Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table North America Cancer Immunotherapies Sales Market Share by End User (2014-2019)
Figure 2018 North America Cancer Immunotherapies Market Share by End User
Figure Europe Cancer Immunotherapies Sales Growth Rate 2014-2019 (K Units)
Figure Europe Cancer Immunotherapies Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Cancer Immunotherapies Sales by Countries (2014-2019) (K Units)
Table Europe Cancer Immunotherapies Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Cancer Immunotherapies Sales Market Share by Countries
Table Europe Cancer Immunotherapies Revenue by Countries (2014-2019) (Million US$)
Table Europe Cancer Immunotherapies Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Cancer Immunotherapies Revenue Market Share by Countries
Figure Germany Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Germany Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure France Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure France Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure UK Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Italy Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Russia Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table Europe Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure 2018 Europe Cancer Immunotherapies Market Share by Product
Table Europe Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table Europe Cancer Immunotherapies Sales Market Share by End User (2014-2019)
Figure 2018 Europe Cancer Immunotherapies Market Share by End User
Figure Asia Pacific Cancer Immunotherapies Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Cancer Immunotherapies Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Cancer Immunotherapies Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Cancer Immunotherapies Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cancer Immunotherapies Sales Market Share by Countries
Table Asia Pacific Cancer Immunotherapies Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Cancer Immunotherapies Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cancer Immunotherapies Revenue Market Share by Countries
Figure China Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure China Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Japan Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Korea Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure India Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure India Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Australia Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table Asia Pacific Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Cancer Immunotherapies Market Share by Product
Table Asia Pacific Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table Asia Pacific Cancer Immunotherapies Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Cancer Immunotherapies Market Share by End User
Figure Central & South America Cancer Immunotherapies Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Cancer Immunotherapies Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Cancer Immunotherapies Sales by Countries (2014-2019) (K Units)
Table Central & South America Cancer Immunotherapies Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cancer Immunotherapies Sales Market Share by Countries
Table Central & South America Cancer Immunotherapies Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Cancer Immunotherapies Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cancer Immunotherapies Revenue Market Share by Countries
Figure Brazil Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table Central & South America Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Cancer Immunotherapies Market Share by Product
Table Central & South America Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table Central & South America Cancer Immunotherapies Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Cancer Immunotherapies Market Share by End User
Figure Middle East and Africa Cancer Immunotherapies Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Cancer Immunotherapies Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Cancer Immunotherapies Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Cancer Immunotherapies Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cancer Immunotherapies Sales Market Share by Countries
Table Middle East and Africa Cancer Immunotherapies Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Cancer Immunotherapies Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cancer Immunotherapies Revenue Market Share by Countries
Figure GCC Countries Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Cancer Immunotherapies Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Cancer Immunotherapies Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Cancer Immunotherapies Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Cancer Immunotherapies Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Cancer Immunotherapies Market Share by Product
Table Middle East and Africa Cancer Immunotherapies Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Cancer Immunotherapies Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Cancer Immunotherapies Market Share by End User
Table Amgen Company Details
Table Amgen Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Roche Company Details
Table Roche Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Bayer Company Details
Table Bayer Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Merck Company Details
Table Merck Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table ARMO BioSciences (Eli Lilly) Company Details
Table ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ARMO BioSciences (Eli Lilly) Recent Development
Table Novartis Company Details
Table Novartis Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Cancer Immunotherapies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table AbbVie Company Details
Table Gilead Sciences Company Details
Table Global Cancer Immunotherapies Sales Forecast by Regions 2019-2025 (K Units)
Table Global Cancer Immunotherapies Sales Market Share Forecast by Regions 2019-2025
Table Global Cancer Immunotherapies Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Cancer Immunotherapies Revenue Market Share Forecast by Regions 2019-2025
Table Global Cancer Immunotherapies Sales Forecast by Product 2019-2025 (K Units)
Table Global Cancer Immunotherapies Sales Market Share Forecast by Product 2019-2025
Table Global Cancer Immunotherapies Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Cancer Immunotherapies Revenue Market Share Forecast by Product 2019-2025
Table Global Cancer Immunotherapies Sales Forecast by End User 2019-2025 (K Units)
Table Global Cancer Immunotherapies Sales Market Share Forecast by End User 2019-2025
Figure North America Cancer Immunotherapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Cancer Immunotherapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Cancer Immunotherapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Cancer Immunotherapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Cancer Immunotherapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Cancer Immunotherapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Cancer Immunotherapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Cancer Immunotherapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Cancer Immunotherapies Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Cancer Immunotherapies Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Cancer Immunotherapies Value Chain
Table Cancer Immunotherapies Customers List
Table Cancer Immunotherapies Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"